Mr Gerassimos Lascaratos

Consultant Ophthalmic Surgeon and Reader in Ophthalmology
MSc(Oxon), MRCSEd, PhD, FRCOphth
Profile photo for Gerassimos Lascaratos

Mr Lascaratos is a Consultant Glaucoma and Cataract surgeon at King’s College Hospital, London and a Reader in Ophthalmology at King's College London (KCL). He specialises in high volume and complex cataract surgery and in the medical, laser and surgical management of all types of adult glaucoma, including cutting edge minimally invasive glaucoma procedures.

English, Greek
New £240 (follow-up £180)


Gerassimos Lascaratos is a Consultant Ophthalmic Surgeon specialising in glaucoma and cataract surgery at King’s College Hospital, London. He is a Reader in Ophthalmology, Faculty of Life Sciences & Medicine at King’s College London and is an internationally recognised expert in his field. 

Mr Lascaratos is a Fellow of the Royal College of Ophthalmologists (FRCOphth) and a member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is also a member of the European Glaucoma Society (EGS) and the European Society of Cataract and Refractive Surgeons (ESCRS). He is the recipient of multiple national and international awards and is currently the co-Chief Investigator for a large multicentre randomised clinical trial on the role of nicotinamide to delay glaucoma progression (NAMinG trial) funded by a prestigious and highly competitive £2.0mil NIHR Efficacy and Mechanism Evaluation (EME) Programme grant.  

Mr Lascaratos prides himself on delivering the highest quality patient care with a focus on patient experience and clinical outcomes. He specialises in the medical, laser and surgical management of all types of adult glaucoma, including trabeculectomy and aqueous shunt devices, cutting edge minimally invasive glaucoma surgery, glaucoma revision surgery and complex cataract surgery, especially in patients with glaucoma. 

His cataract complication rate is less than 0.5 per cent, which is way below the national average, despite the complexity of the operations he performs. He also offers premium intraocular lenses, including toric lenses to correct astigmatism, and multifocal lenses to reduce spectacle dependence for near and distance. 

Mr Lascaratos completed the South Thames surgical training programme in ophthalmology in London and the highly sought-after subspecialty glaucoma fellowship programme at Moorfields Eye Hospital. He was the Clinical Lead for the ophthalmology urgent referral service at King’s College Hospital for several years and has extensive experience in Ophthalmology.

Based on his innovative PhD work in Glaucoma at University College London and his MSc by Research at St Peter’s College, University of Oxford he has international expertise in cellular bioenergetics in glaucoma and has served as the Principal Investigator at King’s College for multiple glaucoma clinical trials to investigate novel glaucoma treatments (intracameral SR bimatoprost, Rho-kinase inhibitors), evaluate emerging biomarkers for glaucoma and understand the molecular mechanisms influencing the outcome of glaucoma filtration surgery. 

More information

119 Harley Street
London W1G 6AU

  • Consultant Ophthalmic Surgeon
    King's College Hospital, London
  • Reader in Ophthalmology
    King's College London
  • Year qualified 2003
  • MSc in Glaucoma, Oxford University, St Peter's College 2007
  • Member of the Royal College of Surgeons (MRCSEd) 2009
  • PhD, University College London 2014
  • Fellow of the Royal College of Ophthalmologists 2015
  • NIHR EME Programme Grant (£2.0mil) to co-lead landmark glaucoma neuroprotection trial (NAMinG trial), 2021
  • NHS Clinical Excellence Award, 2018 - Present
  • International Glaucoma Association/UKEGS Research Award, 2017
  • Fight for Sight New Lecturer Award, 2016
  • Member of the European Glaucoma Panel (EGP) IV and Mentoring Program (2012-2015)
  • AFER/NIHR BRC for Ophthalmology ARVO Travel Award, 2012
  • Royal Society of Medicine Squint Forum Prize, 2010

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Authors: Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G et al.
Year: 2015

The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics
Authors: Lascaratos G, Garway-Heath DF, Burton R, Bunce C et al.
Year: 2013

Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Authors: Lascaratos G, Chau KY, Zhu H, Gkotsi D, King R, Gout I, Kamal D, Luthert PJ, Schapira AHV, Garway-Heath DF.
Year: 2015

Please see more publications from Gerassimos Lascaratos here.


Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.